Atlas Trials

Autologous Hematopoietic Stem Cell Transplant Recipient

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Autologous Hematopoietic Stem Cell Transplant Recipient

RecordFirmDate
Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma (NCT01163357)City of Hope Medical Center2011-01-28

Track Autologous Hematopoietic Stem Cell Transplant Recipient automatically

Every clearance here is in the API, with alerts when new ones post.